RNF5 is identified as a regulator of ERAD-adaptor abundance and NHK processing, while leaving the causal relationship between adaptor regulation and the RNF5-depletion phenotype to be resolved by formal rescue and epistasis studies.
Abstract
Endoplasmic reticulum-associated degradation (ERAD) must dynamically adapt to cellular protein-folding demands, yet mechanisms regulating ERAD-associated adaptors remain incompletely defined. Here, we identify the E3 ubiquitin ligase RNF5 as a regulator of the ERAD adaptors HERPUD1 (HERP1) and OS9. RNF5 depletion increased HERP1 and OS9 protein abundance, while semiquantitative endpoint RT-PCR did not reveal obvious changes in their transcript signals. Available cycloheximide-chase experiments were consistent with increased adaptor persistence and more rapid loss of the ERAD-L substrate null Hong Kong α1-antitrypsin (NHK) after RNF5 depletion. In contrast, expression of the catalytically inactive RNF5 C42S mutant was associated with slower NHK loss, indicating that RNF5 depletion and catalytic inactivation produce distinct functional outcomes. Proteomic screening and co-immunoprecipitation supported association of RNF5 with HERP1- and OS9-containing complexes. RNF5 depletion reduced compound 225-induced HERP1 ubiquitination and adaptor loss, while wild-type RNF5 produced stronger HERP1 ubiquitination than C42S, supporting a contribution of RNF5 catalytic activity. RNF5 depletion also attenuated selected tunicamycin-induced UPR markers and 225-associated cytotoxic/apoptosis-related readouts while increasing SA-β-galactosidase- and γH2AX-associated phenotypes. Together, these findings identify RNF5 as a regulator of ERAD-adaptor abundance and NHK processing, while leaving the causal relationship between adaptor regulation and the RNF5-depletion phenotype to be resolved by formal rescue and epistasis studies.
The chromatin remodeler HELLS (also known as LSH/SMARCA6) is a macromolecular regulator essential for maintaining genomic stability. Here, we identify HELLS as a critical oncogenic driver in prostate cancer and elucidate a previously unrecognized post-translational cascade that governs its protein stability. Mechanisti...
Yu Zhang, Nuorong Xiong, Boxin Du et al.· Biochimica et Biophysica Act...· 0 citations
A non-canonical proteolytic function of USP5 is revealed, uncovering a previously unrecognised regulatory axis linking deubiquitinating enzymes to protein maturation, expanding the substrate repertoire for USP5 and providing a framework for identifying protease–substrate relationships in post-translational regulation.
Liam T. Hales, Paul M. Tammiste, Adam J. Walker et al.· Nature Communications· 1 citation
ARID1B, a key subunit of the SWI/SNF (also known as BAF) chromatin remodeling complex, is characterized as a canonical tumor suppressor across various cancer types. Although the downregulation of ARID1B transcript levels has been observed in many cancers, its regulation at the protein level is comparatively less studie...
Pradipta Hore, Sandipkumar Bambhaniya, M. D. Bashyam· The FEBS Journal· 0 citations
Overall, the findings show that RNF216 and OTUD4 balance rates of protein synthesis and degradation and suggest GHS-related mutations in RNF216 or OTUD4 may offset this balance, triggering neurodegeneration.
Findings reveal a previously underappreciated mechanism of CDDP resistance driven by the FTO/SNHG9/VHL/EZH2/PINK1/Parkin axis and support the therapeutic potential of targeting this pathway in LUAD.
Zihan Jing, Xingmei Ren, Ruqiong Wang et al.· Biochemical Pharmacology· 0 citations
Mitochondrial ubiquitination is a central component of mitochondrial quality control. The PINK1 (PTEN induced kinase 1)-PRKN (parkin RBR E3 ubiquitin protein ligase) pathway established how loss of mitochondrial membrane potential can trigger a phospho-ubiquitin feed-forward cascade on the outer mitochondrial membrane...
Jia-Min Yi, Xin Yong, Da Jia· Autophagy· 0 citations
Related blog posts
MIT News · Artificial Intelligence· news.mit.eduNov 9, 2026
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.